Therefore, it is speculated that CBX 2021 may reduce inflammation by activating the GPCR pathway and downregulating the Notch signaling pathway, thereby effectively reducing intestinal diseases such as diarrhea. This evidence concerns the gene CBX1 and intestinal disorder.